AIM EXAM ARENA
KMU Past Paper Practice
Nausea and Vomiting: Antiemetic Pharmacology
4th Year MBBS • 20 A-type Single Best Answer MCQs
Curriculum basis: supplied antiemetic pharmacology learning outcomes. :contentReference[oaicite:0]{index=0}
MCQ 1
Question:
A 43-year-old woman develops nausea and vomiting several hours after abdominal surgery. She has no vertigo, delayed gastric emptying or previous extrapyramidal reaction. Which drug is most appropriate because it directly blocks serotonin-mediated emetic signalling without dopamine receptor blockade?
Options:
Metoclopramide
Ondansetron
Scopolamine
Domperidone
Lorazepam
Correct Answer: Ondansetron
Explanation: Ondansetron blocks 5-HT3 receptors in peripheral and central emetic pathways and is useful for postoperative nausea without producing dopamine-mediated extrapyramidal effects.
MCQ 2
Question:
A patient receiving radiotherapy develops recurrent treatment-related nausea. The clinician chooses a drug from the same pharmacological class commonly used for acute chemotherapy-induced emesis. Which receptor is the principal therapeutic target?
Options:
Histamine H1 receptor
Muscarinic M1 receptor
Dopamine D2 receptor
Serotonin 5-HT3 receptor
GABA-A receptor
Correct Answer: Serotonin 5-HT3 receptor
Explanation: 5-HT3 antagonists such as ondansetron are useful not only in chemotherapy-associated emesis but also in radiotherapy-related nausea and vomiting.
MCQ 3
Question:
A 62-year-old man has taken metoclopramide repeatedly for several months. He develops persistent involuntary movements of the lips and tongue that continue between doses. Which adverse effect best explains this presentation?
Options:
Tardive dyskinesia
Acute glaucoma
Serotonin syndrome
Vestibular suppression
Adrenal suppression
Correct Answer: Tardive dyskinesia
Explanation: Prolonged central D2 receptor blockade by metoclopramide can produce tardive dyskinesia, characterized by persistent involuntary movements, especially of the face and tongue.
MCQ 4
Question:
A woman taking an antiemetic for recurrent nausea develops breast discharge. She has no dystonia or parkinsonian symptoms. The prescribed drug is known to enter the brain poorly. Which mechanism most likely explains her endocrine adverse effect?
Options:
Central H1 receptor antagonism
Peripheral muscarinic receptor blockade
Serotonin 5-HT3 receptor blockade
Neurokinin NK1 receptor blockade
Dopamine D2 receptor blockade
Correct Answer: Dopamine D2 receptor blockade
Explanation: Domperidone can raise prolactin despite limited CNS penetration because dopamine normally inhibits prolactin release; D2 blockade removes this inhibitory influence.
MCQ 5
Question:
A patient receives metoclopramide for severe nausea. Besides dopamine antagonism and its prokinetic effect, which additional receptor action may contribute to antiemesis when higher drug concentrations are achieved?
Options:
H1 receptor stimulation
M1 receptor stimulation
5-HT3 receptor antagonism
NK1 receptor stimulation
GABA-A receptor antagonism
Correct Answer: 5-HT3 receptor antagonism
Explanation: Metoclopramide primarily blocks D2 receptors and stimulates 5-HT4 receptors, but at higher concentrations it can also antagonize 5-HT3 receptors.
MCQ 6
Question:
A patient at risk of postoperative vomiting receives a serotonin antagonist together with dexamethasone. Which description best explains the role of dexamethasone in this setting?
Options:
It blocks vestibular muscarinic transmission
It enhances antiemetic control through adjunctive central and inflammatory effects
It directly stimulates gastrointestinal dopamine receptors
It selectively antagonizes peripheral H1 receptors
It prevents serotonin formation in enterochromaffin cells
Correct Answer: It enhances antiemetic control through adjunctive central and inflammatory effects
Explanation: Dexamethasone is an effective antiemetic adjunct; its exact mechanism is incompletely defined but includes effects on inflammatory mediators and central emetic signalling.
MCQ 7
Question:
An elderly traveler uses a medication for motion sickness and later develops difficulty passing urine and mild confusion. Which pharmacological action most directly explains these adverse effects?
Options:
Blockade of dopamine D2 receptors
Blockade of serotonin 5-HT3 receptors
Stimulation of serotonin 5-HT4 receptors
Blockade of neurokinin NK1 receptors
Blockade of muscarinic receptors
Correct Answer: Blockade of muscarinic receptors
Explanation: Scopolamine is antimuscarinic; the same receptor blockade that suppresses vestibular emetic transmission can cause urinary retention, blurred vision, dry mouth and confusion.
MCQ 8
Question:
A patient with vestibular nausea receives an antiemetic that readily enters the central nervous system. The drug reduces nausea but also causes drowsiness and some dry mouth. Which drug class best fits this pattern?
Options:
First-generation H1 antihistamines
Selective 5-HT3 antagonists
Peripheral D2 antagonists
NK1 receptor antagonists
Glucocorticoids
Correct Answer: First-generation H1 antihistamines
Explanation: Centrally acting first-generation H1 blockers suppress vestibular emetic signalling; CNS H1 blockade causes sedation and associated antimuscarinic activity can cause dry mouth.
MCQ 9
Question:
A young adult previously developed an acute dystonic reaction after a dopamine-blocking antiemetic. He now requires treatment for postoperative nausea. Which choice best avoids the receptor mechanism responsible for his previous reaction?
Options:
Prochlorperazine
Metoclopramide
Domperidone
Ondansetron
Chlorpromazine
Correct Answer: Ondansetron
Explanation: Ondansetron blocks 5-HT3 rather than D2 receptors, so it avoids the central dopamine blockade responsible for dystonic and other extrapyramidal reactions.
MCQ 10
Question:
A patient with Parkinson disease develops nausea during a course of radiotherapy. The clinician wants an antiemetic that does not oppose dopaminergic treatment. Which pharmacological strategy is most appropriate?
Options:
Central D2 receptor blockade
Phenothiazine receptor blockade
5-HT3 receptor blockade
Central dopamine depletion
Dopamine synthesis inhibition
Correct Answer: 5-HT3 receptor blockade
Explanation: A 5-HT3 antagonist can control treatment-related nausea without blocking central dopamine receptors, making it pharmacologically preferable when dopaminergic function must be preserved.
MCQ 11
Question:
A medical student compares two antiemetic mechanisms. One drug blocks central H1 receptors and also has some antimuscarinic activity. Which clinical problem is most logically suited to this pharmacological profile?
Options:
Motion-related nausea
Delayed chemotherapy emesis
Gastroparesis-related nausea
Conditioned anticipatory nausea
Dopamine-mediated CTZ stimulation
Correct Answer: Motion-related nausea
Explanation: Vestibular emetic pathways depend heavily on H1 and M1 receptors, so centrally acting antihistamines with antimuscarinic activity are particularly useful for motion sickness.
MCQ 12
Question:
A traveler asks why a drug effective for chemotherapy-induced nausea may provide less reliable control of motion sickness. Which explanation best accounts for this difference?
Options:
Motion sickness depends mainly on dopamine D1 receptors
Chemotherapy suppresses vestibular histamine release
Motion sickness is caused by delayed gastric emptying
Chemotherapy nausea is mediated only by cortical pathways
Vestibular emesis relies more strongly on H1 and M1 signalling
Correct Answer: Vestibular emesis relies more strongly on H1 and M1 signalling
Explanation: Motion sickness is predominantly vestibular and therefore responds best to H1 or muscarinic blockade rather than to drugs directed mainly at serotonin-mediated emetic pathways.
MCQ 13
Question:
A pregnant woman with early-pregnancy nausea requires an antihistamine antiemetic. Which drug belongs to the H1 antagonist group and may be used for this purpose according to the treatment options discussed in the topic?
Options:
Aprepitant
Promethazine
Domperidone
Ondansetron
Dexamethasone
Correct Answer: Promethazine
Explanation: Promethazine is a first-generation H1 antagonist with antiemetic activity and is one of the antihistamine options that may be used for pregnancy-related nausea.
MCQ 14
Question:
A pregnant woman has troublesome nausea together with symptoms suggesting delayed gastric emptying. The clinician chooses an antiemetic that can also enhance upper gastrointestinal motility. Which drug has this dual pharmacological profile?
Options:
Scopolamine
Lorazepam
Promethazine
Metoclopramide
Aprepitant
Correct Answer: Metoclopramide
Explanation: Metoclopramide combines antiemetic D2 blockade with 5-HT4-mediated prokinetic activity, making it useful when nausea coexists with impaired gastric emptying.
MCQ 15
Question:
A patient receiving chemotherapy is given a glucocorticoid as part of the antiemetic regimen. A student asks which receptor it specifically blocks in the vomiting pathway. Which response is most accurate?
Options:
It selectively blocks central D2 receptors
It selectively blocks vestibular H1 receptors
Its antiemetic mechanism is not fully defined
It selectively blocks muscarinic M1 receptors
It selectively blocks peripheral 5-HT4 receptors
Correct Answer: Its antiemetic mechanism is not fully defined
Explanation: Dexamethasone has useful antiemetic activity, but unlike receptor-specific drugs, its precise antiemetic mechanism remains incompletely defined.
MCQ 16
Question:
A patient with chemotherapy-associated nausea asks whether lorazepam alone can replace a serotonin antagonist during the acute emetic phase. Which pharmacological explanation best addresses this question?
Options:
Lorazepam directly blocks intestinal 5-HT3 receptors
Lorazepam mainly blocks dopamine receptors in the CTZ
Lorazepam mainly suppresses vestibular muscarinic transmission
Lorazepam mainly antagonizes substance P at NK1 receptors
Lorazepam mainly reduces anxiety and conditioned emetic responses
Correct Answer: Lorazepam mainly reduces anxiety and conditioned emetic responses
Explanation: Benzodiazepines are adjuncts for anticipatory nausea because their GABA-A-mediated anxiolytic effect does not replace direct blockade of serotonin-driven acute CINV.
MCQ 17
Question:
An antiemetic regimen blocks serotonin signalling both at vagal afferent endings in the gastrointestinal tract and within central emetic pathways. Which feature of the drug class best explains its strong effect against acute treatment-related vomiting?
Options:
Combined central and peripheral 5-HT3 blockade
Selective vestibular H1 stimulation
Selective central D1 blockade
Peripheral muscarinic stimulation
Selective GABA-B receptor activation
Correct Answer: Combined central and peripheral 5-HT3 blockade
Explanation: Drugs such as ondansetron inhibit 5-HT3-mediated emetic signalling at both vagal afferents and central emetic sites, giving effective suppression of acute emesis.
MCQ 18
Question:
A clinician compares two dopamine-blocking antiemetics. One produces more sedation, postural hypotension and extrapyramidal reactions and belongs to the neuroleptic group. Which agent most closely fits this description?
Options:
Prochlorperazine
Ondansetron
Scopolamine
Aprepitant
Doxylamine
Correct Answer: Prochlorperazine
Explanation: Prochlorperazine is a phenothiazine neuroleptic antiemetic; D2 blockade provides antiemesis while central and additional receptor effects account for EPS, sedation and hypotension.
MCQ 19
Question:
A woman receiving treatment for nausea has no motor adverse effects but is being monitored for both increased prolactin and cardiac electrical abnormalities. Which antiemetic best matches this combination of features?
Options:
Promethazine
Scopolamine
Ondansetron
Domperidone
Lorazepam
Correct Answer: Domperidone
Explanation: Domperidone can increase prolactin through D2 blockade while its poor CNS penetration limits EPS; QT prolongation remains an important cardiac safety concern.
MCQ 20
Question:
Three patients require antiemetic therapy: one has motion-induced nausea, one has nausea from delayed gastric emptying, and one has treatment-related vomiting driven by serotonin release from the gut. Which drug pairing best matches the dominant mechanism in all three situations?
Options:
Ondansetron for motion sickness; scopolamine for gastroparesis; lorazepam for serotonin-mediated emesis
Domperidone for motion sickness; dexamethasone for gastroparesis; promethazine for serotonin-mediated emesis
Scopolamine for motion sickness; metoclopramide for gastroparesis; ondansetron for serotonin-mediated emesis
Lorazepam for motion sickness; ondansetron for gastroparesis; domperidone for serotonin-mediated emesis
Aprepitant for motion sickness; promethazine for gastroparesis; scopolamine for serotonin-mediated emesis
Correct Answer: Scopolamine for motion sickness; metoclopramide for gastroparesis; ondansetron for serotonin-mediated emesis
Explanation: Scopolamine targets vestibular M1 pathways, metoclopramide adds prokinetic activity, and ondansetron blocks the 5-HT3 pathway activated by intestinal serotonin.